Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
NCT07011342
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
18F-rhPSMA-7.3
Sponsor
Hackensack Meridian Health
Collaborators
[object Object]